---
title: Ergomed Clinical Research vs Velocity Clinical Research
slug_a: medsource
slug_b: velocityclinical
site: cro
review_signal_gate: closed
canonical_path: /compare/medsource/velocityclinical
---

# Ergomed Clinical Research vs Velocity Clinical Research

Side-by-side profile data from each company listing on this directory.

## Ergomed Clinical Research

- Profile: [/companies/medsource](/companies/medsource)

Ergomed Clinical Research — Ergomed is a specialized CRO with 25+ years of experience delivering oncology, rare disease, and complex clinical trial solutions across all phases globally, backed by a team of 100+ MDs and PhDs.

Services: 7. Modalities: 4. Indications: 2. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (7).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Regulatory Affairs
- US FDA Regulatory Strategy

### Modalities

- Small Molecule
- Biologics (Other)
- Cell Therapy
- Gene Therapy

### Indications

- Oncology
- Rare Disease

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## Velocity Clinical Research

- Profile: [/companies/velocityclinical](/companies/velocityclinical)

Velocity Clinical Research — Integrated clinical research site organization operating 60+ sites across the U.S. and Europe, supporting trials that contributed to 61 FDA-approved products since 1986.

Services: 11. Modalities: 5. Indications: 4. Locations: 81. Certifications: 2. The strongest documented coverage currently appears in locations (81).

### Services

- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Medical Writing
- Regulatory Affairs
- US FDA Regulatory Strategy

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Gene Therapy
- Vaccine

### Indications

- Metabolic
- Cardiovascular
- Respiratory
- Women's Health

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)